Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors
Chinese Journal of Cancer · 05.09.2012 · 31 (9) · 413-420
DOI: 10.5732/cjc.012.10102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Journal of Cancer, erschienen am 05.09.2012. Verfasst von Aikseng Ooi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Interdisciplinary Urological Oncology, Van Andel Research Institute, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, NF-E2-Related Factor 2. Die Arbeit wurde bisher 37-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Biallelic inactivation of fumarate hydratase(FH) causes type 2 papillary renal cell carcinoma (PRCC2), uterine fibroids, and cutaneous leimyomas, a condition known as hereditary leiomyomatosis and renal cell cancer(HLRCC). The most direct effect of FH inactivation is intracellular fumarate accumulation. A majority of studies on FH inactivation over the past decade have focused on the theory that intracellular fumarate stabilizes hypoxia-inducible factor 1α(HIF1A) through competitive inhibition of HIF prolyl hydroxylases. Recently, a competing theory that intracellular fumarate activates nuclear factor (erythroid-derived 2)-like 2(NRF2) through post-translational modification of its negative regulator. Kelch-like ECH-associated protein 1(KEAP1) has emerged from a computational modeling study and mouse model studies. This review dissects the origin of these two governing theories and highlights the presence of chromatin-structure-regulated targets of transcription factors, which we refer to as "cryptic targets" of transcription factors. One such cryptic target is heme oxygenase I(HMOX1), the expression of which is known to be modulated by the gene product of SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4 (SMARCA4, also known as BRG1).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Interdisciplinary Urological Oncology, Van Andel Research Institute, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA.
Zitieren
APA
Ooi, A., & Furge, K. A. (2012). Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors. Chinese Journal of Cancer, 31(9), 413-420. https://doi.org/10.5732/cjc.012.10102
Vancouver
Ooi A, Furge KA. Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors. Chinese Journal of Cancer. 2012;31(9):413-420. doi:10.5732/cjc.012.10102
BibTeX
@article{Ooi2012,
author = {Ooi, Aikseng and Furge, Kyle A},
title = {Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors},
journal = {Chinese Journal of Cancer},
year = {2012},
volume = {31},
number = {9},
pages = {413--420},
doi = {10.5732/cjc.012.10102}
}
EUVIMED